Hepatitis C Virus (HCV)–Specific Immune Responses of Long-Term Injection Drug Users Frequently Exposed to HCV

BACKGROUND: Injection drug users (IDUs) who successfully clear hepatitis C virus (HCV) have a reduced risk of developing chronic reinfection, despite their continuing exposure to the virus. To identify immunological correlates for this apparent protection, we studied HCV-specific immune responses in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mizukoshi, Eishiro, Eisenbach, Christoph, Edlin, Brian R., Newton, Kimberly P., Raghuraman, Sukanya, Weiler-Normann, Christina, Tobler, Leslie H., Busch, Michael P., Carrington, Mary, McKeating, Jane A., O’Brien, Thomas R., Rehermann, Barbara
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2699613/
https://ncbi.nlm.nih.gov/pubmed/18505381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/589510
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires